|
1
|
O’Garra A, Redford PS, McNab FW, Bloom CI,
Wilkinson RJ and Berry MP: The immune response in tuberculosis.
Annu Rev Immunol. 31:475–527. 2013. View Article : Google Scholar
|
|
2
|
Zuñiga J, Torres-García D, Santos-Mendoza
T, Rodriguez-Reyna TS, Granados J and Yunis EJ: Cellular and
humoral mechanisms involved in the control of tuberculosis. Clin
Dev Immunol. 2012:1939232012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Yang W, Lu J, Weng J, Jia W, Ji L, Xiao J,
Shan Z, Liu J, Tian H, Ji Q, Zhu D, Ge J, Lin L, Chen L, Guo X,
Zhao Z, Li Q, Zhou Z, Shan G and He J: China National Diabetes and
Metabolic Disorders Study Group: Prevalence of diabetes among men
and women in China. N Engl J Med. 362:1090–1101. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Friis H, Range N, Pedersen ML, Mølgaard C,
Changalucha J, Krarup H, Magnussen P, Søborg C and Andersen AB:
Hypovitaminosis D is common among pulmonary tuberculosis patients
in Tanzania but is not explained by the acute phase response. J
Nutr. 138:2474–2480. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Arnedo-Pena A, Juan-Cerdán JV,
Romeu-Garcia A, Garcia-Ferrer D, Holguín-Gómez R, Iborra-Millet J,
Herrero-Carot C, Piñana MJ, Bellido-Blasco J, Ferrero-Vega JA,
Adsuara LS, Silvestre ES, Ferrer NM and Bartual VR: Latent
tuberculosis infection, tuberculin skin test and vitamin D status
in contacts of tuberculosis patients: a cross-sectional and
case-control study. BMC Infect Dis. 11:3492011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chun RF, Adams JS and Hewison M:
Immunomodulation by vitamin D: implications for TB. Expert Rev Clin
Pharmacol. 4:583–591. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Cadranel J, Garabedian M, Milleron B,
Guillozo H, Akoun G and Hance AJ: 1,25(OH)2D2
production by T lymphocytes and alveolar macrophages recovered by
lavage from normocalcemic patients with tuberculosis. J Clin
Invest. 85:1588–1593. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Baeke F, Takiishi T, Korf H, Gysemans C
and Mathieu C: Vitamin D: modulator of the immune system. Curr Opin
Pharmacol. 10:482–496. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Desai NS, Tukvadze N, Frediani JK, Kipiani
M, Sanikidze E, Nichols MM, Hebbar G, Kempker RR, Mirtskhulava V,
Kalandadze I, Seydafkan S, Sutaria N, Chen TC, Blumberg HM, Ziegler
TR and Tangpricha V: Effects of sunlight and diet on vitamin D
status of pulmonary tuberculosis patients in Tbilisi, Georgia.
Nutrition. 28:362–366. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Choi HS, Kim KA, Lim CY, Rhee SY, Hwang
YC, Kim KM, Kim KJ, Rhee Y and Lim SK: Low serum vitamin D is
associated with high risk of diabetes in Korean adults. J Nutr.
141:1524–1528. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Chagas CE, Borges MC, Martini LA and
Rogero MM: Focus on vitamin D, inflammation and type 2 diabetes.
Nutrients. 4:52–67. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Dalgård C, Petersen MS, Weihe P and
Grandjean P: Vitamin D status in relation to glucose metabolism and
type 2 diabetes in septuagenarians. Diabetes Care. 34:1284–1288.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Biyoudi-Vouenze R, Cadranel J, Valeyre D,
Milleron B, Hance AJ and Soler P: Expression of
1,25(OH)2D3 receptors on alveolar lymphocytes
from patients with pulmonary granulomatous diseases. Am Rev Respir
Dis. 143:1376–1380. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kota SK, Jammula S, Kota SK, Tripathy PR,
Panda S and Modi KD: Effect of vitamin D supplementation in type 2
diabetes patients with pulmonary tuberculosis. Diabetes Metab
Syndr. 5:85–89. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yamshchikov AV, Kurbatova EV, et al:
Vitamin D status and antimicrobial peptide cathelicidin (LL-37)
concentrations in patients with active pulmonary tuberculosis. Am J
Clin Nutr. 92:603–611. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Rivas-Santiago B, Rivas, Santiago CE,
Castañeda-Delgado JE, León-Contreras JC, Hancock RE and
Hernandez-Pando R: Activity of LL-37, CRAMP and antimicrobial
peptide-derived compounds E2, E6 and CP26 against Mycobacterium
tuberculosis. Int J Antimicrob Agents. 41:143–148. 2013. View Article : Google Scholar
|
|
17
|
Martineau AR, Newton SM, Wilkinson KA,
Kampmann B, Hall BM, Nawroly N, Packe GE, Davidson RN, Griffiths CJ
and Wilkinson RJ: Neutrophil-mediated innate immune resistance to
mycobacteria. J Clin Invest. 117:1988–1994. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Vidyarani M, Selvaraj P, Jawahar MS and
Narayanan PR: 1,25 Dihydroxyvitamin D3 modulated
cytokine response in pulmonary tuberculosis. Cytokine. 40:128–134.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Okamoto Yoshida Y, Umemura M, et al:
Essential role of IL-17A in the formation of a mycobacterial
infection-induced granuloma in the lung. J Immunol. 184:4414–4422.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Umemura M, Yahagi A, Hamada S, et al:
IL-17-mediated regulation of innate and acquired immune response
against pulmonary Mycobacterium bovis bacille Calmette-Guerin
infection. J Immunol. 178:3786–3796. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Salahuddin N, Ali F, Hasan Z, Rao N, Aqeel
M and Mahmood F: Vitamin D accelerates clinical recovery from
tuberculosis: results of the SUCCINCT Study [Supplementary
Cholecalciferol in recovery from tuberculosis]. A randomized,
placebo-controlled, clinical trial of vitamin D supplementation in
patients with pulmonary tuberculosis’. BMC Infect Dis. 13:222013.
View Article : Google Scholar
|
|
22
|
Rathored J, Sharma SK, Singh B, et al:
Risk and outcome of multidrug-resistant tuberculosis: vitamin D
receptor polymorphisms and serum 25(OH)D. Int J Tuberc Lung Dis.
16:1522–1528. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Mily A, Rekha RS, Kamal SM, Akhtar E,
Sarker P, Rahim Z, Gudmundsson GH, Agerberth B and Raqib R: Oral
intake of phenylbutyrate with or without vitamin D3
upregulates the cathelicidin LL-37 in human macrophages: a dose
finding study for treatment of tuberculosis. BMC Pulm Med.
13:232013. View Article : Google Scholar
|
|
24
|
Selvaraj P, Harishankar M, Singh B,
Banurekha VV and Jawahar MS: Effect of vitamin D3 on
chemokine expression in pulmonary tuberculosis. Cytokine.
60:212–219. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Prabhu Anand S, Selvaraj P and Narayanan
PR: Effect of 1,25 dihydroxyvitamin D3 on intracellular
IFN-gamma and TNF-alpha positive T cell subsets in pulmonary
tuberculosis. Cytokine. 45:105–110. 2009. View Article : Google Scholar
|
|
26
|
Kumar NP, Sridhar R, Banurekha VV, Jawahar
MS, Nutman TB and Babu S: Expansion of pathogen-specific T-helper 1
and T-helper 17 cells in pulmonary tuberculosis with coincident
type 2 diabetes mellitus. J Infect Dis. 208:739–748. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yu Y, Zhang Y, Hu S, Jin D, Chen X, Jin Q
and Liu H: Different patterns of cytokines and chemokines combined
with IFN-γ production reflect Mycobacterium tuberculosis infection
and disease. PLoS One. 7:e449442012. View Article : Google Scholar
|
|
28
|
Whitworth HS, Scott M, Connell DW, Dongés
B and Lalvani A: IGRAs - the gateway to T cell based TB diagnosis.
Methods. 61:52–62. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Martineau AR, Timms PM, Bothamley GH,
Hanifa Y, Islam K, Claxton AP, Packe GE, Moore-Gillon JC,
Darmalingam M, Davidson RN, Milburn HJ, Baker LV, Barker RD,
Woodward NJ, Venton TR, Barnes KE, Mullett CJ, Coussens AK,
Rutterford CM, Mein CA, Davies GR, Wilkinson RJ, Nikolayevskyy V,
Drobniewski FA, Eldridge SM and Griffiths CJ: High-dose vitamin
D3 during intensive-phase antimicrobial treatment of
pulmonary tuberculosis: a double-blind randomised controlled trial.
Lancet. 377:242–250. 2011. View Article : Google Scholar : PubMed/NCBI
|
